Literature DB >> 21803757

Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.

O Valkenburg1, A G Uitterlinden, A P Themmen, F H de Jong, A Hofman, B C J M Fauser, J S E Laven.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is characterized by ovarian dysfunction. The association with obesity and insulin resistance is well established. Steroid hormones play a central role in the regulation of both ovarian function and body composition. This study aims to assess the influence of known functional polymorphisms in genes that are responsible for the production, metabolism and signal transduction of steroid hormones on the susceptibility to and phenotype of PCOS.
METHODS: We included 518 Caucasian women with anovulatory PCOS (2003 Rotterdam criteria) and 2996 population-based controls. Functional polymorphic variants were selected in genes that affect the production of estradiol and cortisol [aromatase (CYP19), 11-beta-hydroxysteroid dehydrogenase type I (HSD11B1) and hexose-6-phosphate dehydogenase (H6PD)] and in genes for signal transduction proteins [estrogen receptor (ESR1 and ESR2) and glucocorticoid receptor (GCR)].
RESULTS: Genotype-frequencies were similar in PCOS cases and population-based controls. We observed possible associations between GCR genotype and LH levels that suggest an inhibitory influence of GCR, i.e., lower LH levels in association with GCR alleles that are known to increase receptor sensitivity (rs6195 and rs41423247) and higher LH levels in GCR variants that may inhibit receptor sensitivity (rs6190 and rs6198).
CONCLUSIONS: The present study did not identify risk alleles for PCOS, although the study was limited by an absence of endocrine data for the population-based controls. However, GCR variants may influence gonadotrophin levels in women with anovulatory PCOS. We hypothesize that glucocorticoids can affect the function of the hypothalomo-pituitary-gonadal axis in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803757     DOI: 10.1093/humrep/der222

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  H6PD Gene Polymorphisms (R453Q and D151A) and Polycystic Ovary Syndrome: A Case-Control Study in A Population of Iranian Kurdish Women.

Authors:  Rozita Naseri; Yosra Alimoradi; Maryam Sohrabi; Mostafa Cheraghian Fard; Elahe Barzingarosi; Amir Abdolmaleki; Cyrus Jalili
Journal:  Int J Fertil Steril       Date:  2022-08-21

2.  Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome.

Authors:  Vince Kornél Grolmusz; Orsolya Dóra Acs; Karolina Feldman-Kovács; Ágnes Szappanos; Balázs Stenczer; Tibor Fekete; György Szendei; Péter Reismann; Károly Rácz; Attila Patócs
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

3.  Association of DENND1A Gene Polymorphisms with Polycystic Ovary Syndrome: A Meta-Analysis.

Authors:  Shan Bao; Jun Hong Cai; Shu Ying Yang; Yongchao Ren; Tian Feng; Tianbo Jin; Zhuo Ri Li
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18

4.  Variant Alleles of the ESR1, PPARG, HMGA2, and MTHFR Genes Are Associated With Polycystic Ovary Syndrome Risk in a Chinese Population: A Case-Control Study.

Authors:  Xianting Jiao; Weiwei Chen; Jun Zhang; Weiye Wang; Junjiao Song; Dan Chen; Wenting Zhu; Yuhua Shi; Xiaodan Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

5.  Association of Estrogen Receptor Genes Polymorphisms With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Based on Observational Studies.

Authors:  Siyu Zhou; Shu Wen; Yongcheng Sheng; Meina Yang; Xiaoyang Shen; Yan Chen; Deying Kang; Liangzhi Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-04       Impact factor: 5.555

6.  Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population.

Authors:  Rong Ju; Wei Wu; Qiuqin Tang; Di Wu; Yankai Xia; Jie Wu; Xinru Wang
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

7.  Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome.

Authors:  Gustavo A Rosa Maciel; Ricardo P P Moreira; Diogo D G Bugano; Sylvia A Y Hayashida; José A M Marcondes; Larissa G Gomes; Berenice B Mendonça; Tânia A S S Bachega; Edmund C Baracat
Journal:  Clinics (Sao Paulo)       Date:  2014-03       Impact factor: 2.365

8.  Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy.

Authors:  Michael Schneider; Anne Engel; Peter A Fasching; Lothar Häberle; Elisabeth B Binder; Franziska Voigt; Jennifer Grimm; Florian Faschingbauer; Anna Eichler; Ulf Dammer; Dirk Rebhan; Manuela Amann; Eva Raabe; Tamme W Goecke; Carina Quast; Matthias W Beckmann; Johannes Kornhuber; Anna Seifert; Stefanie Burghaus
Journal:  Biomed Res Int       Date:  2014-03-12       Impact factor: 3.411

9.  Role of Single Nucleotide Variants in FSHR, GNRHR, ESR2 and LHCGR Genes in Adolescents with Polycystic Ovary Syndrome.

Authors:  Lasma Lidaka; Laine Bekere; Adele Rota; Jekaterina Isakova; Gunta Lazdane; Anda Kivite-Urtane; Iveta Dzivite-Krisane; Inga Kempa; Zane Dobele; Linda Gailite
Journal:  Diagnostics (Basel)       Date:  2021-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.